Stay updated on Nivolumab±Ipilimumab in Ovarian & Clear Cell Carcinomas Clinical Trial
Sign up to get notified when there's something new on the Nivolumab±Ipilimumab in Ovarian & Clear Cell Carcinomas Clinical Trial page.

Latest updates to the Nivolumab±Ipilimumab in Ovarian & Clear Cell Carcinomas Clinical Trial page
- Check2 days agoChange DetectedThe page now displays Revision: v3.3.4, replacing Revision: v3.3.3; to avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check9 days agoNo Change Detected
- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedAdded a consolidated Locations section listing Illinois and Rhode Island sites. Removed the separate Illinois Locations and Rhode Island Locations sections as part of revision v3.3.3.SummaryDifference0.3%

- Check52 days agoChange DetectedRevision label updated from v3.2.0 to v3.3.2 on the page; this affects only metadata and does not alter study information.SummaryDifference0.1%

- Check59 days agoChange DetectedRemoved the government funding lapse notice about the NIH Clinical Center's operating status. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check73 days agoChange DetectedThere are no substantive changes to the study details between the screenshots. Any differences observed are minor frontend formatting or layout tweaks.SummaryDifference0.4%

- Check95 days agoChange DetectedThe page now adds several future and recent dates (including 2025-10-09, 2026-01, 2026-03, 2025-10-07) and an Estimated Last Update, while removing older dates (2025-05-04, 2025-07, 2025-05-02) and the plain 'Last Update Posted' entry. This indicates a shift in update schedule and timestamps rather than changes to core content or offerings.SummaryDifference0.9%

Stay in the know with updates to Nivolumab±Ipilimumab in Ovarian & Clear Cell Carcinomas Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab±Ipilimumab in Ovarian & Clear Cell Carcinomas Clinical Trial page.